In a randomized clinical trial of competing strategies, patients were nearly twice as compliant with colorectal screening when offered a choice of screening options.
Offer patients the choice of Cologuard®, an option with high sensitivity, high compliance, and patient satisfaction.
REFERENCE 1. Inadomi JM, Vijan S, Janz NK, et al. Adherence to colorectal cancer screening: a randomized clinical trial of competing strategies. Arch Intern Med. 2012;172(7):575-582. 2. This study was done at a single health network in San Francisco comprising of a racially and ethnically diverse population; it was a 3-month cluster randomization design into 3 arms over an 18-month study period. Results varied by ethnicity.